Philippe Marchand
Private Equity Analist bij Investissement Québec
Profiel
Philippe Marchand is currently an Analyst at Investissement Québec since 2019.
Prior to this, he held positions as Principal at Edwards Lifesciences Corp., CryoCath Technologies, Inc., and Senior Engineer-Research & Development at ev3, Inc. He also worked as Manager-Research & Development at Sequent Medical, Inc. Marchand received his undergraduate and graduate degrees from McGill University.
Actieve functies van Philippe Marchand
| Bedrijven | Functie | Begin |
|---|---|---|
Investissement Québec
 Investissement Québec Investment ManagersFinance Investissement Québec (Investissement Quebec) is a Private Equity/Venture Capital firm, a subsidiary of Province of Québec founded in 1998. The firm is headquartered in Montréal. | Private Equity Analist | 07-01-2019 |
Eerdere bekende functies van Philippe Marchand
| Bedrijven | Functie | Einde |
|---|---|---|
ev3, Inc.
 ev3, Inc. Medical SpecialtiesHealth Technology ev3, Inc. is a provider for specialists treating a range of vascular diseases and disorders. ev3 is committed to the peripheral vascular and neurovascular markets offering a portfolio of treatment options, including interventional technologies used such as plaque excision systems, PTA balloons, stents, embolic protection, thrombectomy, embolization coils, liquid embolics, occlusion balloons and procedural support. | Hoofd Techniek/Wetenschap/O&O | - |
| EDWARDS LIFESCIENCES CORPORATION | Corporate Officer/Principal | - |
CryoCath Technologies, Inc.
 CryoCath Technologies, Inc. Medical SpecialtiesHealth Technology CryoCath Technologies, Inc. manufactures medical equipment. The company was founded by Normand Balthazard and Andre L. Lamotte in 1994 and is headquartered in Montreal, QC. | Corporate Officer/Principal | - |
Sequent Medical, Inc.
 Sequent Medical, Inc. Medical SpecialtiesHealth Technology Sequent Medical, Inc. operates as a medical device company. It develops catheter-based neurovascular technologies. The company was founded by Robert F. Rosenbluth and Brian J. Cox in August 2007 and is headquartered in Aliso Viejo, CA. | Hoofd Techniek/Wetenschap/O&O | - |
Opleiding van Philippe Marchand
| McGill University | Graduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| EDWARDS LIFESCIENCES CORPORATION | Health Technology |
| Bedrijven in privébezit | 4 |
|---|---|
Sequent Medical, Inc.
Sequent Medical, Inc. Medical SpecialtiesHealth Technology Sequent Medical, Inc. operates as a medical device company. It develops catheter-based neurovascular technologies. The company was founded by Robert F. Rosenbluth and Brian J. Cox in August 2007 and is headquartered in Aliso Viejo, CA. | Health Technology |
CryoCath Technologies, Inc.
CryoCath Technologies, Inc. Medical SpecialtiesHealth Technology CryoCath Technologies, Inc. manufactures medical equipment. The company was founded by Normand Balthazard and Andre L. Lamotte in 1994 and is headquartered in Montreal, QC. | Health Technology |
ev3, Inc.
ev3, Inc. Medical SpecialtiesHealth Technology ev3, Inc. is a provider for specialists treating a range of vascular diseases and disorders. ev3 is committed to the peripheral vascular and neurovascular markets offering a portfolio of treatment options, including interventional technologies used such as plaque excision systems, PTA balloons, stents, embolic protection, thrombectomy, embolization coils, liquid embolics, occlusion balloons and procedural support. | Health Technology |
Investissement Québec
Investissement Québec Investment ManagersFinance Investissement Québec (Investissement Quebec) is a Private Equity/Venture Capital firm, a subsidiary of Province of Québec founded in 1998. The firm is headquartered in Montréal. | Finance |
